Curaleaf CEO on Expanding its Global Footprint

U.S. cannabis company is entering the burgeoning European cannabis market through a deal to acquire Emmac Life Sciences. The $286 million acquisition grants Curaleaf valuable exposure to a growing market. Curaleaf CEO Joe Bayern joined Cheddar to discuss.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.